Pernix Therapeutics Balance Sheet - Quarterly (NASDAQ:PTX)

Add to My Stocks
$1.44 $0.06 (4%) PTX stock closing price Aug 17, 2018 (Closing)

A thorough fundamental analysis involves using data from Pernix Therapeutics balance sheet, apart from other financial statements, to value the business. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Pernix Therapeutics stock analysis, and provides insights into the firm's financial performance. Quarterly results are typically accompanied with the company releasing financial statements. Pernix Therapeutics had a long term debt of $214.24M at the end of 2018 Q2. To understand the debt servicing capacity of the company, one needs to look at Pernix Therapeutics operating cash flow and Pernix Therapeutics revenue also. Pernix Therapeutics debt to equity ratio is -.

View and download Pernix Therapeutics quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Cash19.93M26.94M32.82M27.24M14.34M22.73M36.37M28.52M29.2M46.64M
Marketable Securities----------
Receivables35.38M37.07M45.44M48.79M45.69M31.68M52.14M48.12M55.47M58.61M
Inventory5.06M5.4M5.39M8.13M8.48M7.44M7.77M8.28M9.69M11.82M
Raw Materials---1.73M1.87M1.97M2.36M1.5M1.78M1.84M
Work In Progress---------1.45M
Finished Goods5.87M6.33M5.88M6.87M7.31M6.73M7.39M9.73M11.4M11.98M
Notes Receivable----------
Other Current Assets6.1M7.29M10.11M8.81M13.31M15.06M12.61M13.25M11.65M12.11M
Total Current Assets
66.46M76.71M93.77M92.98M81.83M76.93M108.91M98.18M106.02M129.2M
Property Plant & Equipment--1.66M---1.8M---
Accumulated Depreciation----------
Net Property Plant & Equipment
-----1.01M1.1M1.19M1.28M2.45M
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Intangibles97.52M98.9M108.7M145.38M163.53M181.68M200.17M274.5M295.12M317.25M
Deposits & Other Assets1.97M2.11M2.26M2.4M------
Total Assets
166.63M178.4M205.49M241.6M246.48M259.86M310.44M374.16M402.74M449.24M
Notes Payable-3.66M11.1M15.04M------
Accounts Payable10.8M8.79M7.91M22.69M23.09M20.39M7.27M23.13M-37.4M
Current Portion Long-Term Debt----14M-----
Current Portion Capital Leases----------
Accrued Expenses61.01M70.06M68.96M58.25M55.73M55.81M75.02M56.35M81.42M62.48M
Income Taxes Payable----------
Other Current Liabilities14.29M8.61M13.26M12.66M16.17M11.24M16.12M11M15.68M21.3M
Total Current Liabilities
86.09M87.47M93.8M93.61M109M87.44M109.52M91.12M100.89M121.19M
Mortgages----------
Deferred Taxes/Income----------
Convertible Debt66.93M66.05M65.73M64.87M106.37M105.21M104.07M102.95M101.87M100.81M
Long-Term Debt214.24M212.77M214.24M50.03M173.1M14M14M198M198.2M203.27M
Non-Current Capital Leases----------
Other Long-Term Liabilities4.4M4.53M5.97M176.32M21.71M195.97M196.9M11.92M11.25M15.28M
Total Liabilities
371.65M370.84M379.74M384.85M410.19M402.63M424.5M404.23M412.45M440.63M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus262.49M261.55M261.15M259.79M245.71M245.05M244.3M242.16M240.88M228.3M
Retained Earnings-467.63M-454.11M-435.53M-403.11M-409.47M-387.85M-358.39M-272.31M-245.87M-214.73M
Treasury Stock--------5.57M5.56M
Other Liabilities----0.04M-0.05M-0.07M-0.07M-0.01M--
Shareholders Equity-205.02M-192.44M-174.25M-143.24M-163.71M-142.77M-114.06M-30.06M-9.71M8.61M
Total Liabilities & Shareholders Equity166.63M178.4M205.49M241.6M246.48M259.86M310.44M374.16M402.74M449.24M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The latest Pernix Therapeutics stock price, and Pernix Therapeutics historical stock prices show the stock price movement over time, and the Pernix Therapeutics PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: An asset is a resource that a corporation like Pernix Therapeutics owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for PTX stock as of 2018 Q2 is $166.63M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. PTX stock had total liabilities of $371.65M for the quarter 2018 Q2.

Pernix Therapeutics Balance Sheet - Key Ratios

Current ratio
0.77
Debt to equity ratio
0
Asset turnover ratio
0.49
Receivables turnover
3.09